Eden Research Share Discussion Threads

[supersonico] 15/7/2019 14:56

Cheer up Fellas.. I've told you what's coming:)

[investingisatrickygame] 15/7/2019 13:48

Eden's share price performance is dismal, pathetic in fact. 4-5 years of going nowhere for a company operating in a high growth stock market, a tech business in one of the world's biggest and most important sectors to humanity.

Given those circumstances, 40p wouldn't make up for those years gone by.

Eden has no focus on shareholders and share price and it shows. These things need a much greater emphasis and effort if the shares are to get to what they're currently worth.

[northwick] 15/7/2019 13:07

Apart from Cricket, do we have anything else to cheer about???What a load of !!!!Maybe, we should revisit Eden in 4 years time, like the World Cup!

[supersonico] 14/7/2019 11:15

Agrauxine inaugurates its new head office and laboratories on the “vegetal campus” at Beaucouzé, France



“Lesaffre is focusing on the search for innovative solutions based on fermentation, intended for food which is healthier and more sustainable for the planet. Lesaffre is investing in particular in human, animal and plant health nutrition. Agrauxine is the business unit that is leading this strategy in plant health nutrition,” explains Antoine Baule, CEO of Lesaffre.

[supersonico] 13/7/2019 07:19

The Italian bioeconomy at the top in Europe
Over 330 billion euros in annual revenue, 2 million jobs. Goal plus 15% by 2030



The conference "The Italian bioeconomy: situation and prospects", held at the National Academy of Agriculture in Bologna analyzed "the future strategy of the European Union, which aims to invest between 8 and 10 billion euros on the competitiveness of the Bioeconomy, and the positive repercussions in terms of environmental regeneration, protection of biodiversity and increase in jobs ".
The main speaker, Fabio Fava, of the University of Bologna and Italian representative for the bioeconomy in the European Community, explained that «the bio-economy includes the various sectors of primary production: agriculture, livestock, forests, fisheries and aquaculture, industrial sectors that use or transform bio-resources from these sectors, such as the food and feed industry, that of cellulose, paper and wood processing, together with biorefineries, that is part of the chemical and energy industries , and aside from the marine-marine industry, in Europe the bioeconomy has an annual turnover of around 2,300 billion euros with more than 18 million jobs. The Italian bioeconomy is third in Europe, after the German and French ones, with an annual turnover of over 330 billion euros and almost 2 million jobs. Our country is also second in Europe in terms of research and innovation (such as presence in projects funded by the EU commission in the field of bioeconomy) and often the first in terms of wealth in biodiversity, innovative products and quality placed on the market , but it requires greater coordination between Ministries and between Ministries and Regions, as well as among the actors in the public and private sector active in the various fields of the bioeconomy ".

Fava recalled that "in addition to this, the bioeconomy, with its possibility of producing better quality food and feed in greater quantities, but also chemical compounds and biocompatible fuels from renewable raw material alternative to oil, thus guaranteeing safety and food quality, reduction of environmental pollution and climate change, represents the main solution to the growing demand for food resulting from the progressive growth of the world population and the decrease in traditional and non-renewable raw materials. Not only that, the bioeconomy regenerates the environment, limits the loss of biodiversity and the great transformations in the use of the land, creating new economic and occupational growth, especially youth, starting from the specificities and local traditions, particularly in rural areas, coastal and industrial areas experienced by the current economic crisis. Finally, the efficient use of renewable biological resources, with a more sustainable primary production and more efficient transformation systems for the production of food, fiber and other bio-based products with less use of production factors, less waste production and greenhouse gas emissions, such as the enhancement of organic waste from agriculture, forests, cities and industry (primarily food), guarantee the bioeconomy a key role in the circular economy. The implementation of the aforementioned actions requires research and innovation aimed at strengthening the industrial-production areas mentioned above and integrating them, creating new or longer value chains, set in the territory, together with specific training and information actions. We also need a shared vision between the institutions and the main public-private actors in the sector regarding the economic, social and environmental opportunities of the same, the challenges connected with the implementation of an integrated bioeconomy in the territory and the necessary implementation actions. In 2012, Europe set itself an ambitious strategy in the sector, providing for important funding to support research and innovation in the context of Horizon 2020 and the Public Private Partnership "Bio-based Industries", as well as the creation of the "Bioeconomy Panel" . Another date has recently been given, a revised version with respect to the previous one, which will address the future framework program, Horizon EU, which will see research and innovation support for the bioeconomy between 8 and 10 billion euros ".

Fava also illustrated the Italian national strategy: "Hence, therefore, Italy's decision to adopt a first national bioeconomy strategy in 2016, the" Italian Strategy for the Bioeconomy "(BIT), presented in 2017, signed by 5 Ministries (Ministry of Agricultural, Food and Forestry Policies; Ministry of Education, University and Research; Ministry of Economic Development; Ministry of the Environment, Protection of the Territory and the Sea; Ministry of Territorial and Southern Cohesion), the Conference of Regions and Autonomous Provinces, the Agency for Territorial Cohesion and the National Technological Clusters for Green Chemistry (SPRING) and Agri-food (CLAN). But also that of having an updated one, a BIT II, ​​which takes into account the new opportunities of the country and the priorities identified by the European strategy of 2018. It was attended by 4 ministries (Ministry of Agriculture, Food, Forestry and Tourism; Ministry of Agriculture Education, University and Research, Ministry of Economic Development, Ministry of the Environment, Protection of the Territory and the Sea), the Conference of Regions and Autonomous Provinces, and National Technological Clusters for Green Chemistry (SPRING) and Agri-food (CLAN) and blue growth.

Fava concluded by recalling the Italian objectives for the future: "The strategy aims at 2030 to achieve a 15% increase in economic activities and jobs currently attributable to the Italian bioeconomy. There are two actions planned to achieve the goal. The first is to improve the sustainable production and quality of products in each of the sectors (from those of primary production to those of transformation), making more efficient use of the interconnections between them, with a precise valorisation of both terrestrial and marine biodiversity, of the ecosystem services and circularity, the creation of new value chains, longer and more deeply rooted in the territory, which can allow the regeneration of abandoned areas, marginal lands and abandoned industrial sites. The second is to create more investments in research and innovation, spin off / start-up, education, training and communication; improve coordination between stakeholders and policies at regional, national and EU level; improve the involvement of the public, and carry out actions aimed at developing the market for biobased products. The actions of the strategic bioeconomy agenda and the priorities are accompanied by measures aimed at guaranteeing the framework conditions necessary for its effective implementation ".

[investingisatrickygame] 12/7/2019 14:13

If the Bod is to exercise their forthcoming share options, due date 30th September 2019 they better get a move on

45 days before is the 15th August 2019

45 working days before is Wednesday the 31st July 2019

Are they going to lapse through lack of share price performance? 50% option award for a 45 day weighted average share price of 20p, pro-rata through to 30p for a 100% option award.

To have them lapse again would be bad and show a lack of focus on the share price and therefore performance. The investment community will be even more mindful of investing in Eden.

If they are going to be exercised, what event, transactional in my opinion, is going to occur very soon to elevate and hold the share price in this range of above?

All opinions welcome, but there must be an event because there is no momentum whatsoever and we have another days of nil transactions in Eden

Regarding the share price:-

#notsustainable
#underperformance
#generallyregardedasunsafe
#notnatural
#upforsale

[investingisatrickygame] 12/7/2019 10:12

Well, they are bog standard and highly relevant questions, all of which can and should be answered.

When you don't do these things, appetite for your shares disappears. I note we haven't had one trade in Eden shares since 5/7/2019....a whole week!!!!!!!

In that respect, this has to be the worst week for Eden and their shareholders for a very long time.

Investors will just run if and when the price rises.

[supersonico] 12/7/2019 07:15

Investing,

We're more likely to have TT deliver on time than you get answers to those questions.

[investingisatrickygame] 11/7/2019 21:47

Questions that the BoD could communicate answers to deliver explanation and confidence in the market

1) Why did you decide to remove your Broker, Shore Capital and why did you choose Cenkos Securities?

2) What assets and skill sets do Cenkos possess that are over and above their predecessor(s)?

3) How will these features of Cenkos manifest themselves in terms of the Eden share register and share price activity?

4) As with 3), what activities will take place to support the share price?

5) What remit has been given to Cenkos and is this more expansive and complete than was given to their predecessor? In other words, in light of 2) do they warrant a broader remit than others and will they have the time, resources and right connections to positively exercise it?

5) Does the remit of Cenkos go above market making and institutional support and if so, please explain how?

6) Will Cenkos be delivering a new Research paper detailing Eden and the financial possibilities over the next three years & a target price based on the same and if so, is Eden confident that these values will be more reflective of value than the last broker report issued?

7) What does Eden management think the shares are worth today? (no investment advice, just pure opinion)

8) Does management believe they will be able to exercise their forthcoming share options with an exercise date of the 30th of September 2019. (no explanation needed if yes, if a maybe answer then some broad high level qualification of the same)

Go on Proactive Investors and deliver a story like the above to create better understanding, explanation and value and if done properly I bet you Eden's shares will be substantially higher than they are now and in 'rea' short order that most ordinary folk understand

[supersonico] 11/7/2019 15:48

Good LUCK.

[dplewis1] 11/7/2019 15:20

Sonic mine is the 100k at 3.024. Let's hope it's more interesting than bloody EDEN..

[supersonico] 11/7/2019 13:37

Northwick.

I'm wader deep in both already ..they are both strong buys imo with in the coming strong short order news flow.

With SEE I believe the Fleet Issue that bought shares down has been fixed and a near term update will show recovery well on track. They also have 5 Auto RFQ''s any of which could land and some favourable Aviation news sounds imminent.

Eden news that I have flagged is not priced in imo. The thing to watch with EDEN is incongruence , delays, New York and Potential strategic Investor so I look forward to that jigsaw evolving.

[northwick] 11/7/2019 13:29

SuperMight it not be a better option to buy more of Eden shares knowing what you already know? Unless, of course, is this already priced in? Our new brokers have made little attempt to engage in the markets!

[supersonico] 11/7/2019 11:54

FYI.. SEE expecting news on Volvo win ..II's buying ..

[supersonico] 11/7/2019 11:17

Small-scale farms 'would solve' environment crisis, group says.

New report from @DaveGoulson for Food Research Collaboration. "Small-scale farms 'would solve' environment crisis." Redirect a chunk of the ca £5Bn English farm subsidies and tax breaks - towards agroecology.

[supersonico] 10/7/2019 06:59

Not sure of the workings of the Patent list but it's movements are worth noting imo as it maybe one way of gauging what lurks below the water line on the Edenberg.

This Patent moves to Number 1 slot displacing the 1964 Patent I have mentioned before. Both may well be SustainE related imo.

ENDURA SPA [IT]; SIPCAM SPA

A METHOD FOR MODULATING THE RELEASE RATE OF MICROENCAPSULATED ACTIVE INGREDIENTS

A method for modulating the release rate of microencapsulated active ingredients comprising the following steps: I) preparation of an aqueous suspension A) comprising microcapsules of at least one active ingredient, II) preparation of a liquid emulsifiable in water, component B), comprising a solvent of the active ingredient and at least a surfactant, III) water, component C), for diluting to the application dose the active ingredient, and mixing A), B) and C).



Sipcam Patents list.



UN PROCEDIMIENTO PARA LA PRODUCCIÓN DE UN COMPUESTO DE ACCIÓN ALTAMENTE ANTICRIPTOGÁMICA @1964

.

[supersonico] 09/7/2019 15:03

Endocrine disruptors
Presentation and ANSES's work in the field

[supersonico] 09/7/2019 07:08

Non-Hodgkin’s Lymphoma Resulted From Decades of Exposure to Roundup, Lawsuit Alleges

[supersonico] 09/7/2019 06:44

This latest study clears shows that glyphosate causes cancer at levels lower than permitted by regulators. Andre Leu

Glyphosate induces benign monoclonal gammopathy and promotes multiple myeloma progression in mice



Conclusions
Our data provide in vivo evidence to support that glyphosate induces MGUS and promotes disease progression to MM. We uncover a B cell-specific mutational mechanism for glyphosate exposure that increases MM and NHL risk, providing a molecular basis for human epidemiological findings. Given the increasing use of glyphosate in the USA and worldwide, the present study supports epidemiological reports and informs the EPA and other agencies during the regulatory development of current and emerging glyphosate-based herbicidal products.

[supersonico] 08/7/2019 23:02

NoPest seeks alternatives to traditional pesticides




The European project NoPest -in which researchers from the University of La Rioja participate- will develop sustainable alternatives to the use of traditional pesticides against crop diseases, mainly downy mildew on grapes and potatoes.

Started in January 2019, the NoPest project (Novel Pesticides for a Sustainable Agriculture) is part of the 'Future and Emerging Technologies Open' program (Horizon 2020) of the European Union and has a financing of more than three million euros for its five years of expected duration.

In the international consortium - which has recently met at the University of La Rioja - the University of Milan (Italy), responsible for the coordination of the project, also participates; the Kungliga Tekniska Hoegskolan (Sweden), the Universite Paris-Sud (France) and the Bar Ilan University (Israel), together with the multinational company Sipcam Oxon.

The international team of scientists proposes the use of organic compounds that prevent the development of the fungi that cause some of the main diseases in agriculture, such as mildew. The new fungicides will be obtained from proteins capable of recognizing and interacting with specific target molecules. In this case, they will inhibit the action of enzymes involved in the formation of the cell wall of fungi, destroying them.

These products, designed and optimized in the laboratory, would replace the traditional phytosanitary products used to combat mildew (copper and other chemical compounds), whose massive use causes pollution, residual toxicity and adverse effects on human health. The project will thus contribute to a safer and more respectful agriculture with the environment.

The professor of Viticulture of Precision of the University of La Rioja, Javier Tardáguila, emphasizes that 'the compounds obtained will be combined with tools of precision agriculture, designing technologies and innovative tools to monitor the incidence of diseases and ensuring the proper functioning of this new generation of phytosanitary products'.

Tardáguila coordinates the scientists of the University of La Rioja involved in the project, belonging to the research group Televitis (specialized in new technologies and non-invasive sensors in viticulture), the Engineering Department (experts in environmental impact assessment) and the Department of Economy (responsible for the analysis of the economic and social impact of the new phytosanitary products).

[supersonico] 08/7/2019 20:21

Nous verrons
………………...

Virginia Grape Disease Updates

Of course, once I mentioned the lack of rainfall, we (i.e., northern VA) were hit by a series of rain. To make things more complicated, we had at least three consecutive nights of warm and humid (RH > 90%) condition prior to the rains. Humid nights encourage downy mildew pathogen to produce spores, and rains will splash spores to healthy tissues. Thus, the risk of downy mildew during recent rain events was very high. (Note: Central VA also had two humid nights in 7/5-7/6 at the Charlottesville airport, but the chance of rain is not high until this Thursday.)

[supersonico] 08/7/2019 17:14

Did we change Brokers to sort out a Placing ?

[supersonico] 08/7/2019 06:42

Investing.

I care about TT as it has huge potential as does CAP imo. We don't yet know the real reason for the delays so until then we await news on the actual value of the prize.